Maerkl Lab
@maerkl-lab.bsky.social
We are a research laboratory at the Ecole Polytechnique Federale de Lausanne (EPFL) in Switzerland focusing on cell-free synthetic biology, synthetic cell engineering and microfluidics.
Check out Amogh's latest review:
"Microfluidics meets cell-free systems: from molecular engineering to synthetic cells"
now published in Current Opinion in Biotechnology.
www.sciencedirect.com/science/arti...
"Microfluidics meets cell-free systems: from molecular engineering to synthetic cells"
now published in Current Opinion in Biotechnology.
www.sciencedirect.com/science/arti...
Microfluidics meets cell-free systems: from molecular engineering to synthetic cells
Cell-free systems have emerged as a powerful platform for protein production, characterization, and bottom-up construction of artificial cells, offeri…
www.sciencedirect.com
November 24, 2025 at 1:01 PM
Check out Amogh's latest review:
"Microfluidics meets cell-free systems: from molecular engineering to synthetic cells"
now published in Current Opinion in Biotechnology.
www.sciencedirect.com/science/arti...
"Microfluidics meets cell-free systems: from molecular engineering to synthetic cells"
now published in Current Opinion in Biotechnology.
www.sciencedirect.com/science/arti...
Reposted by Maerkl Lab
High-throughput cell-free profiling of SARS-CoV-2 RBD variants enables rapid and quantitative in vitro affinity landscape mapping https://www.biorxiv.org/content/10.1101/2025.09.23.678000v1
September 24, 2025 at 3:05 AM
High-throughput cell-free profiling of SARS-CoV-2 RBD variants enables rapid and quantitative in vitro affinity landscape mapping https://www.biorxiv.org/content/10.1101/2025.09.23.678000v1
Reposted by Maerkl Lab
High-throughput cell-free profiling of SARS-CoV-2 RBD variants enables rapid and quantitative in vitro affinity landscape mapping https://www.biorxiv.org/content/10.1101/2025.09.23.678000v1
September 24, 2025 at 3:05 AM
High-throughput cell-free profiling of SARS-CoV-2 RBD variants enables rapid and quantitative in vitro affinity landscape mapping https://www.biorxiv.org/content/10.1101/2025.09.23.678000v1
Laura and Jiami's paper is out now on BioRxiv! Nice collaboration with the Reddy lab at ETHZ:
"High-throughput cell-free profiling of SARS-CoV-2 RBD variants enables rapid and quantitative in vitro affinity landscape mapping."
www.biorxiv.org/content/10.1...
"High-throughput cell-free profiling of SARS-CoV-2 RBD variants enables rapid and quantitative in vitro affinity landscape mapping."
www.biorxiv.org/content/10.1...
High-throughput cell-free profiling of SARS-CoV-2 RBD variants enables rapid and quantitative in vitro affinity landscape mapping
SARS-CoV-2 variants continue to threaten public health, necessitating the study of cumulative and epistatic effects of receptor-binding domain (RBD) mutations on antibody evasion. We present a high-th...
www.biorxiv.org
September 24, 2025 at 12:03 PM
Laura and Jiami's paper is out now on BioRxiv! Nice collaboration with the Reddy lab at ETHZ:
"High-throughput cell-free profiling of SARS-CoV-2 RBD variants enables rapid and quantitative in vitro affinity landscape mapping."
www.biorxiv.org/content/10.1...
"High-throughput cell-free profiling of SARS-CoV-2 RBD variants enables rapid and quantitative in vitro affinity landscape mapping."
www.biorxiv.org/content/10.1...
Hello World !!
The Maerkl Lab is now on Bluesky...
#syntheticbiology #cellfree #microfluidics #transcriptinalregulation
The Maerkl Lab is now on Bluesky...
#syntheticbiology #cellfree #microfluidics #transcriptinalregulation
September 2, 2025 at 1:05 PM
Hello World !!
The Maerkl Lab is now on Bluesky...
#syntheticbiology #cellfree #microfluidics #transcriptinalregulation
The Maerkl Lab is now on Bluesky...
#syntheticbiology #cellfree #microfluidics #transcriptinalregulation